Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase

Autor: Pivonello, Rosario *, Fleseriu, Maria, Newell-Price, John, Bertagna, Xavier, Findling, James, Shimatsu, Akira, Gu, Feng, Auchus, Richard, Leelawattana, Rattana, Lee, Eun Jig, Kim, Jung Hee, Lacroix, André, Laplanche, Audrey, O'Connell, Paul, Tauchmanova, Libuse, Pedroncelli, Alberto M, Biller, Beverly M K
Zdroj: In The Lancet Diabetes & Endocrinology September 2020 8(9):748-761
Databáze: ScienceDirect